Amphenol Corporation
—- Market cap
- $103.47B
- Debt
- —
- Cash
- −$11.13B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: APH stock price vs CGNX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CGNX's multiple
Needs CGNX P/E.
Implied fair value · at APH's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AMPHENOL CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
COGNEX CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TE Connectivity plc
APH vs TEL
CORNING INC /NY
APH vs GLW
CommScope Holding Company, Inc.
APH vs COMM
HUBBELL INC
APH vs HUBB
BEL FUSE INC /NJ
APH vs BELFA
VISHAY INTERTECHNOLOGY INC
APH vs VSH
TELEDYNE TECHNOLOGIES INC
APH vs TDY
TERADYNE, INC
APH vs TER
ZEBRA TECHNOLOGIES CORP
APH vs ZBRA
METTLER TOLEDO INTERNATIONAL INC/
APH vs MTD
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe APH can sustain its superior margin and return profile while the market continues to value it more like CGNX on earnings and sales multiples, then buying or holding APH makes sense because CGNX-implied upside is large at 102.3% and APH is the stronger operator in the dataset.
On CGNX-based valuation framework, APH’s implied price of $333.02 suggests 102.3% upside from the current $164.59, indicating a meaningful discount to CGNX multiple view. However, APH also sits above its historical band of $148.13 to $181.05, while the DCF range of $38.21 to $51.70 implies the stock may be expensive under more conservative cash-flow assumptions.
Supporting Metrics